COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore Tianrong YeoRachel Wan En SiewKevin Tan Original Communication 07 April 2023 Pages: 2817 - 2825
Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome in patients with COVID-19 infection: is there a link? A systematic review and case report analysis Adriano BonuraGianmarco IaccarinoFabio Pilato Review 04 April 2023 Pages: 2826 - 2852
Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report Johannes WischmannLaura M. BartosIlias Masouris Letter to the Editors Open access 03 April 2023 Pages: 2853 - 2856
Non-visual hallucinations in Parkinson’s disease: a systematic review Wei Lin TohCaitlin YollandSusan L. Rossell Review Open access 27 January 2023 Pages: 2857 - 2889
Effects of motor–cognitive training on dual-task performance in people with Parkinson’s disease: a systematic review and meta-analysis Hanna JohanssonAnn-Kristin FolkertsBreiffni Leavy Review Open access 23 February 2023 Pages: 2890 - 2907
The effect of exercise on cognitive function in people with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials Gen LiQiuping YouLaikang Yu Review 02 March 2023 Pages: 2908 - 2923
Endovascular treatment achieves better outcomes than best medical management in patients with M2 occlusion and high stroke severity: a meta-analysis Yu GuoHao WuHeng-zhu Zhang Review 02 March 2023 Pages: 2924 - 2937
Left- vs right-sided migraine: a scoping review Adam S. Sprouse BlumNina Y. RigginsBenjamin Littenberg Review 07 March 2023 Pages: 2938 - 2949
Different monoclonal antibodies and immunosuppressants administration in patients with neuromyelitis optica spectrum disorder: a Bayesian network meta-analysis Ziqian YinYoujia QiuGang Chen Review Open access 08 March 2023 Pages: 2950 - 2963
The effect of levodopa treatment on vascular endothelial function in Parkinson’s disease Min Seung KimDon Gueu ParkJung Han Yoon Original Communication 15 February 2023 Pages: 2964 - 2968
Determinant of the cerebellar cognitive affective syndrome in Friedreich’s ataxia V. DestrebecqC. CometG. Naeije Original Communication 15 February 2023 Pages: 2969 - 2974
Peripheral nervous system adverse events associated with immune checkpoint inhibitors Simone RossiFrancesco GelsominoMaria Guarino Original Communication Open access 17 February 2023 Pages: 2975 - 2986
Sjögren’s syndrome with and without neurological involvement Tabea SeeligerEmelie KramerDiana Ernst Original Communication Open access 18 February 2023 Pages: 2987 - 2996
Neurofilament light chain levels indicate acute axonal damage under bortezomib treatment Nadine CebullaDaniel SchirmerClaudia Sommer Original Communication Open access 18 February 2023 Pages: 2997 - 3007
The association of subjective sleep characteristics and plasma biomarkers of Alzheimer’s disease pathology in older cognitively unimpaired adults with higher amyloid-β burden Heling ChuChuyi HuangQihao Guo Original Communication 20 February 2023 Pages: 3008 - 3021
Is dementia more likely following traumatic brain injury? A systematic review John Gerrard HanrahanCharlotte BurfordPeter John Hutchinson Original Communication 22 February 2023 Pages: 3022 - 3051
Safety of lumbar puncture for people who are treated with ADP receptor antagonists Mary NashSivan BlochDaniel Golan Original Communication 23 February 2023 Pages: 3052 - 3057
Supporting brain health in multiple sclerosis: exploring the potential of neuroeducation combined with practical mindfulness exercises in the management of neuropsychological symptoms Sharon Jean BaetgeMelanie FilserIris-Katharina Penner Original Communication Open access 25 February 2023 Pages: 3058 - 3071
Deep phenotyping of frontal lobe epilepsy compared to other epilepsy syndromes Ryan W. S. WeeAdina NashHeather Angus-Leppan Original Communication 27 February 2023 Pages: 3072 - 3081
Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry Sebastian MichelsDeborah Kurzthe ALS Registry Swabia Study Group Original Communication Open access 28 February 2023 Pages: 3082 - 3090
In vivo characterization of microglia and myelin relation in multiple sclerosis by combined 11C-PBR28 PET and synthetic MRI Valeria T. BarlettaElena HerranzCaterina Mainero Original Communication 02 March 2023 Pages: 3091 - 3102
Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing–remitting multiple sclerosis in Austria Michael GugerChristian Enzingerthe Austrian MS Treatment Registry (AMSTR) Original Communication Open access 02 March 2023 Pages: 3103 - 3111
Neuromuscular junction involvement in inherited motor neuropathies: genetic heterogeneity and effect of oral salbutamol treatment Grace McMackenRoger G. WhittakerRita Horvath Original Communication Open access 04 March 2023 Pages: 3112 - 3119
Profiling cognitive–motor interference in a large sample of persons with progressive multiple sclerosis and impaired processing speed: results from the CogEx study R. VeldkampM. D’hoogethe CogEx Research Team Original Communication 07 March 2023 Pages: 3120 - 3128
Ravulizumab pharmacokinetics and pharmacodynamics in patients with generalized myasthenia gravis Tuan VuStephan OrtizJames F. Howard Jr. Original Communication Open access 09 March 2023 Pages: 3129 - 3137
Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 1 Chi D. L. NguyenAura Cecilia Jimenez-MorenoAndreas Roos Original Communication 09 March 2023 Pages: 3138 - 3158
Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer’s disease: an expert opinion and practical guideline Massimo FilippiGiordano CecchettiFederica Agosta Original Communication Open access 09 March 2023 Pages: 3159 - 3170
Influence of RBD onset on the clinical characteristics of Parkinson’s disease patients: a retrospective study Calogero Edoardo CiceroAntonina LucaAlessandra Nicoletti Original Communication 10 March 2023 Pages: 3171 - 3178
Individual reserve in aging and neurological disease Roee HoltzerJaeun ChoiMark E. Wagshul Original Communication 12 March 2023 Pages: 3179 - 3191
The influence of culture and cognitive reserve on the clinical presentation of behavioural-variant frontotemporal dementia A. SkeggsG. WeiFiona Kumfor Original Communication Open access 14 March 2023 Pages: 3192 - 3203
Split-elbow sign in the PRO-ACT and Southern Italy ALS cohorts: a potential marker of disease severity and lower motor neuron involvement? Stefano ZoccolellaGiammarco MilellaGiancarlo Logroscino Original Communication 14 March 2023 Pages: 3204 - 3212
Abnormal thalamic functional connectivity correlates with cardiorespiratory fitness and physical activity in progressive multiple sclerosis Francesco RomanòRobert W. MotlCogEx Research Team Original Communication 18 March 2023 Pages: 3213 - 3224
Mutation screening of AOPEP variants in a large dystonia cohort Junyu LinChunyu LiHuifang Shang Original Communication 18 March 2023 Pages: 3225 - 3233
Former participation in professional football as an occupation in patients with isolated REM sleep behavior disorder leading to a synucleinopathy: a case–control study Alejandra CollíaAlex IranzoCarles Gaig Original Communication 20 March 2023 Pages: 3234 - 3242
The Boston criteria version 2.0 increase the proportion of lobar intracerebral haemorrhage classified as probable cerebral amyloid angiopathy Yang DuWenpeng ZhangDavid J. Werring Letter to the Editors 19 January 2023 Pages: 3243 - 3245
Sporadic Fatal Insomnia presenting with agrypnia excitata and rapidly progressive dementia: a case report Miryam CannizzaroValentina PieriMassimo Filippi Letter to the Editors 22 February 2023 Pages: 3246 - 3251
Development of a diagnostic framework for vestibular causes of dizziness and unsteadiness in patients with multisensory neurological disease: a Delphi consensus Amanda J. MaleSarah L. HolmesDiego Kaski Letter to the Editors 26 February 2023 Pages: 3252 - 3257
Untreated anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia progressing over 27 years E. SchegkI. BeiserM. Gschwind Letter to the Editors Open access 01 March 2023 Pages: 3258 - 3260
Deep brain stimulation for patients with dystonia in Machado–Joseph disease: three case reports Jun IkezawaFusako YokochiKazushi Takahashi Letter to the Editors 02 March 2023 Pages: 3261 - 3265
Additive effect of DNAJC30 and NDUFA9 mutations causing Leigh syndrome Claudia NestiChiara TicciElena Procopio Letter to the Editors 20 March 2023 Pages: 3266 - 3269
The clinical and genetic spectrum of primary familial brain calcification Miryam CarecchioMichele MainardiGiulia Bonato Neurological Update Open access 02 March 2023 Pages: 3270 - 3277
Édouard Claparède (1873–1940) Penelope A. KollarouLazaros C. Triarhou Pioneers in Neurology 10 April 2023 Pages: 3280 - 3282
Correction to: Hypocortisolism as an unusual but treatable cause of dystonia‑parkinsonism Clément DesjardinsMarie MonginBertrand Degos Correction 13 March 2023 Pages: 3283 - 3283
Correction to: Motor, cognitive and behavioural profiles of C9orf72 expansion-related amyotrophic lateral sclerosis Eleonora ColomboBarbara PolettiNicola Ticozzi Correction Open access 13 March 2023 Pages: 3284 - 3285
Correction to: Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis Eleonora ColomboAlberto DorettiNicola Ticozzi Correction Open access 13 March 2023 Pages: 3286 - 3287
Correction to: Comparing characteristics and outcomes of in-hospital stroke and community-onset stroke Zi-Yue LiuGuang-Song HanYi-Cheng Zhu Correction 28 March 2023 Pages: 3288 - 3288